MinnieAbromowitchMD

Pediatric Hematology & Oncology • Omaha, NE

Professor of Pediatrics, University Nebr College of Medicine

Join to view full profile

Dr. Abromowitch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Abromowitch's full profile

Already have an account?

Office
childrens hospital and medical center
8200 dodge st.
Omaha, NE 68114
Phone+1 402-955-5470

Fax+1 402-955-3972
Is this information wrong?

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 1979 - 1980
University of ManitobaClass of 1973

Certifications & Licensure

NE State Medical License 1991 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013

Clinical Trials

Combination Chemotherapy in Treating Children With Lymphoma Start of enrollment: 1994 Jul 01
Completed
Phase 2
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma Start of enrollment: 2000 Jun 01
Completed
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Start of enrollment: 2006 Feb 20
Completed
Phase 3
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Start of enrollment: 2008 Dec 08
Active, not recruiting
Phase 3
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
Completed
Phase 3
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Active, not recruiting
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer Start of enrollment: 2017 Nov 29
Recruiting
Phase 3
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
EGFR Exon 20 Insertion in Bithalamic and Unithalamic Glioma: A Report of 2 Cases and Literature Review.
Ashley L Hein, Sahara J Cathcart, Allison Cushman-Vokoun, Nicole A Shonka, Minnie Abromowitch, Michael Punsoni, Jie Chen> ;Journal of Neuropathology and Experimental Neurology. 2022 Oct 18
8 citations
Genomic characterization of pediatric B‐lymphoblastic lymphoma and B‐lymphoblastic leukemia using formalin‐fixed tissues
Julia Meyer, Delu Zhou, Clinton C. Mason, Jonathan M. Downie, Vladimir Rodic, Minnie Abromowitch, Birte Wistinghausen, Amanda M. Termuhlen, Anne L. Angiolillo, Sherrie...> ;Pediatric Blood & Cancer. 2017 Jul 1
6 citations
Myeloid Sarcoma in the Orbit
Xiaoxiao Qian, James W Gigantelli, Minnie Abromowitch, Linda A. Morgan, Donny W. Suh> ;Journal of Pediatric Ophthalmology and Strabismus. 2016 Dec 8
2 citations
Isolated central nervous system primary acute monoblastic leukemia presenting as papilledema.
Christopher Park, Donny W. Suh, Allison Ramey, Cody Heston, Minnie Abromowitch> ;Pediatric Blood & Cancer. 2016 Aug 28
49 citations
Disseminated lymphoblastic lymphoma in children and adolescents: Results of the COG A5971 trial: A report from the Children's Oncology Group
Amanda M. Termuhlen, Lynette M. Smith, Sherrie L. Perkins, Mark A. Lones, Jonathan L. Finlay, Howard J. Weinstein, Thomas G. Gross, Minnie Abromowitch> ;British Journal of Haematology. 2013 Sep 1
32 citations
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: A report from the Children'...
Amanda M. Termuhlen, Lynette M. Smith, Sherrie L. Perkins, Mark A. Lones, Jonathan L. Finlay, Howard J. Weinstein, Thomas G. Gross, Minnie Abromowitch> ;Pediatric Blood & Cancer. 2012 Dec 15
58 citations
The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children’s Oncology Group report
Jay Patel, Lynette M. Smith, James R. Anderson, Minnie Abromowitch, Dario Campana, Jeffrey Jacobsen, Mark A. Lones, Thomas G. Gross, Mitchell S. Cairo, Sherrie L. Perkins> ;British Journal of Haematology. 2012 Nov 1
1 citations
Onset of Adreno-Leukodystrophy After Medulloblastoma Therapy: Causal Connection or Coincidence?
G. Deib, Andrea Poretti, Avner Meoded, Kenneth J. Cohen, G. V. Raymond, Minnie Abromowitch, T.A.G.M. Huisman> ;JIMD Reports. 2011 Sep 6
74 citations
Minimal Disseminated Disease in Childhood T-Cell Lymphoblastic Lymphoma: A Report From the Children's Oncology Group
Elaine Coustan-Smith, John T. Sandlund, Sherrie L. Perkins, Helen Chen, Myron Chang, Minnie Abromowitch, Dario Campana> ;Journal of Clinical Oncology. 2009 Jul 20
83 citations
Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941
Eric J. Lowe, Richard Sposto, Sherrie L. Perkins, Thomas G. Gross, Jonathan L. Finlay, David L. Zwick, Minnie Abromowitch> ;Pediatric Blood & Cancer. 2009 Mar 1
17 citations
Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group.
Kristi J. Smock, Marilu Nelson, Sheryl R. Tripp, Warren G. Sanger, Minnie Abromowitch, Mitchell S. Cairo, Sherrie L. Perkins> ;Pediatric Blood & Cancer. 2008 Oct 1
40 citations
Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from...
Minnie Abromowitch, Richard Sposto, Sherrie L. Perkins, David L. Zwick, Stuart E. Siegel, Jonathan L. Finlay, Mitchell S. Cairo> ;British Journal of Haematology. 2008 Oct 1
145 citations
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
Girish Dhall, Howard Grodman, Lingyun Ji, Stephen A. Sands, Sharon Gardner, Ira J. Dunkel, Geoffrey McCowage, Blanca Diez, Jeffrey C. Allen, Anjali Gopalan, Albert Cor...> ;Pediatric Blood & Cancer. 2008 Jun 1
80 citations
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed su...
Jason R. Fangusaro, Jonathan L. Finlay, Richard Sposto, Lingyun Ji, Monirath Saly, Stergios Zacharoulis, Shahab Asgharzadeh, Minnie Abromowitch, Randal Olshefski, Stev...> ;Pediatric Blood & Cancer. 2008 Feb 1
49 citations
Cerebral metastasis and other central nervous system complications of pleuropulmonary blastoma.
John R. Priest, Jeffrey Magnuson, Gretchen M. Williams, Minnie Abromowitch, Rebecca L. Byrd, Philippa G. Sprinz, Marsha Finkelstein, Christopher L. Moertel, D. Ashley ...> ;Pediatric Blood & Cancer. 2007 Sep 1
36 citations
Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08.
Mark A. Lones, Nyla A. Heerema, Michelle M. Le Beau, Richard Sposto, Sherrie L. Perkins, Marshall E. Kadin, Carl R. Kjeldsberg, Anna T. Meadows, Stuart E. Siegel, Jona...> ;Cancer Genetics and Cytogenetics. 2007 Jan 1
6 citations
Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08.
Mark A. Lones, Nyla A. Heerema, Michelle M. Le Beau, Sherrie L. Perkins, Marshall E. Kadin, Carl R. Kjeldsberg, Richard Sposto, Anna T. Meadows, Stuart E. Siegel, Jona...> ;Cancer Genetics and Cytogenetics. 2006 Dec 1
52 citations
Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisa...
Sherrie L. Perkins, Diane L. Pickering, Eric J. Lowe, David L. Zwick, Minnie Abromowitch, Ginny Davenport, Mitchell S. Cairo, Warren G. Sanger> ;British Journal of Haematology. 2005 Dec 1
60 citations
Autologous Hematopoietic Stem-Cell Transplantation for Relapsed or Refractory Hodgkin's Disease in Children and Adolescents
K. Scott Baker, Bruce Geoffrey Gordon, Thomas G. Gross, Minnie Abromowitch, Elizabeth Lyden, James C. Lynch, Julie M. Vose, James O. Armitage, Peter F. Coccia, Philip ...> ;Journal of Clinical Oncology. 1999 Mar 1
3 citations
Fatal coagulase-negative staphylococci infection after bone marrow transplantation in a patient with persistent adverse reactions to vancomycin.
K. G. Heuermann, Jose R. Romero, Minnie Abromowitch, Bruce Geoffrey Gordon, Thomas G. Gross> ;Journal of Pediatric Hematology/oncology. 1999 Jan 1
20 citations
Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated ...
Bruce Geoffrey Gordon, Phyllis I. Warkentin, S. E. Strandjord, Minnie Abromowitch, E. Bayever, James Harper, Peter F. Coccia> ;Bone Marrow Transplantation. 1997 Jul 1
11 citations
Large cell non-Hodgkin lymphoma of childhood: clinical characteristics and outcome.
John T. Sandlund, Victor M. Santana, Minnie Abromowitch, Raul C. Ribeiro, Hazem Mahmoud, Gregory D. Ayers, Jin Sying Lin, Robert E. Hutchison, Costan W. Berard, Carol ...> ;Leukemia. 1994 Jan 1
8 citations
MACOP-B treatment in children and adolescents with advanced diffuse large-cell non-Hodgkin's lymphoma
Victor M. Santana, Minnie Abromowitch, John T. Sandlund, Frederick G. Behm, Gregory D. Ayers, Paula K. Roberson, Ching-Hon Pui> ;Leukemia. 1993 Feb 1
114 citations
Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease.
Melissa M. Hudson, Carol A. Greenwald, Elizabeth D. Thompson, Judith A. Wilimas, Neyssa Marina, Diane L. Fairclough, William Kauffman, Paula M. Bozeman, Paul W. Macker...> ;Journal of Clinical Oncology. 1993 Jan 1
36 citations
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X.
Ching-Hon Pui, Richard K. Dodge, A T Look, Stephen L. George, Gaston K. Rivera, M Abromowitch, J Ochs, William E. Evans, W M Crist, Joseph V. Simone> ;Journal of Clinical Oncology. 1991 Aug 1
Join now to see all